Literature DB >> 29423559

Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulation.

Jacob E Kurlander1,2,3, Geoffrey D Barnes4, Michelle A Anderson4, Brian Haymart4, Eva Kline-Rogers4, Scott Kaatz5, Sameer D Saini4,6, Sarah L Krein4,6, Caroline R Richardson7, James B Froehlich4.   

Abstract

To understand how physicians from various specialties perceive coordination of care when managing peri-procedural anticoagulation. Cross-sectional survey of cardiologists, gastroenterologists, and primary care physicians (PCPs) in an integrated health system (N = 251). The survey began with a vignette of a patient with atrial fibrillation co-managed by his PCP, cardiologist, and an anticoagulation clinic who must hold warfarin for a colonoscopy. Respondents' experiences and opinions around responsibilities and institutional support for managing peri-procedural anticoagulation were elicited using multiple choice questions. We examined differences in responses across specialties using Chi square analysis. The response rate was 51% (n = 127). 52% were PCPs, 28% cardiologists, and 21% gastroenterologists. Nearly half (47.2%) of respondents believed that the cardiologist should be primarily responsible for managing peri-procedural anticoagulation, while fewer identified the PCP (25.2%), anticoagulation clinic (21.3%), or gastroenterologist (6.3%; p = 0.09). Respondents across specialties had significantly different approaches to deciding how to manage the clinical case presented (p < 0.001). Most cardiologists (60.0%) would decide whether to offer bridging without consulting with other providers or clinical resources, while most PCPs would decide after consulting clinical resources (57.6%). Gastroenterologists would most often (46.2%) defer the decision to another provider. A majority of all three specialties agreed that their institution could do more to help manage peri-procedural anticoagulation, and there was broad support (88.1%) for anticoagulation clinics' managing all aspects of peri-procedural anticoagulation. Providers across specialties agree that their institution could do more to help manage peri-procedural anticoagulation, and overwhelmingly support anticoagulation clinics' taking responsibility.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Bridging; Colonoscopy; Coordination of care; Endoscopy; Warfarin

Mesh:

Substances:

Year:  2018        PMID: 29423559      PMCID: PMC7061901          DOI: 10.1007/s11239-018-1625-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  17 in total

1.  Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

Authors:  David Garcia; John H Alexander; Lars Wallentin; Daniel M Wojdyla; Laine Thomas; Michael Hanna; Sana M Al-Khatib; Paul Dorian; Jack Ansell; Patrick Commerford; Greg Flaker; Fernando Lanas; Dragos Vinereanu; Denis Xavier; Elaine M Hylek; Claes Held; Freek W A Verheugt; Christopher B Granger; Renato D Lopes
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Authors:  Jeff S Healey; John Eikelboom; James Douketis; Lars Wallentin; Jonas Oldgren; Sean Yang; Ellison Themeles; Hein Heidbuchel; Hein Heidbuchle; Alvaro Avezum; Paul Reilly; Stuart J Connolly; Salim Yusuf; Michael Ezekowitz
Journal:  Circulation       Date:  2012-06-14       Impact factor: 29.690

4.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Authors:  James D Douketis; Alex C Spyropoulos; Scott Kaatz; Richard C Becker; Joseph A Caprini; Andrew S Dunn; David A Garcia; Alan Jacobson; Amir K Jaffer; David F Kong; Sam Schulman; Alexander G G Turpie; Vic Hasselblad; Thomas L Ortel
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

5.  Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.

Authors:  Sean D Pokorney; DaJuanicia N Simon; Laine Thomas; Gregg C Fonarow; Peter R Kowey; Paul Chang; Daniel E Singer; Jack Ansell; Rosalia G Blanco; Bernard Gersh; Kenneth W Mahaffey; Elaine M Hylek; Alan S Go; Jonathan P Piccini; Eric D Peterson
Journal:  Am Heart J       Date:  2015-04-01       Impact factor: 4.749

6.  Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.

Authors:  T-H Kim; J-Y Kim; H-S Mun; H-Y Lee; Y H Roh; J-S Uhm; H-N Pak; M-H Lee; B Joung
Journal:  J Thromb Haemost       Date:  2015-01-07       Impact factor: 5.824

Review 7.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

8.  Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants.

Authors:  Geoffrey D Barnes; Brahmajee K Nallamothu; Anne E Sales; James B Froehlich
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-03-01

Review 9.  Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.

Authors:  Gemma Mas Dalmau; Elisenda Sant Arderiu; María Belén Enfedaque Montes; Ivan Solà; Sandra Pequeño Saco; Pablo Alonso Coello
Journal:  BMC Fam Pract       Date:  2017-01-13       Impact factor: 2.497

10.  Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Eric D Peterson; Sunghee Kim; Laine Thomas; Bernard J Gersh; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Matthew W Sherwood; Paul Chang; Jonathan P Piccini; Jack Ansell
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690

View more
  2 in total

1.  Assessment of a Best Practice Alert and Referral Process for Preprocedure Antithrombotic Medication Management for Patients Undergoing Gastrointestinal Endoscopic Procedures.

Authors:  Geoffrey D Barnes; Elizabeth Spranger; Emily Sippola; Elizabeth Renner; Allison Ruff; Anne E Sales; Jacob E Kurlander
Journal:  JAMA Netw Open       Date:  2020-02-05

2.  A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant.

Authors:  James D Douketis; Summer Syed; Na Li; Samer Narouze; Mansoor Radwi; Joanne Duncan; Sam Schulman; Alex C Spyropoulos
Journal:  Res Pract Thromb Haemost       Date:  2020-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.